Purchase Order 75F40124P00394
Award Date 8/21/24
Potential Completion Date 8/21/25
Potential Value $49K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...
- Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip technology, was awarded a $145,260 firm fixed-price purchase order by the Food and Drug Administration on August 1, 2024. The contract calls for delivery of the CHIP-S1 Stretchable Chip (catalog number 10231-2) with an ultimate completion date of August 31, 2024. This award was designated as a Total Small Business set-aside, recognizing Emulate's status as a small business entity. The Food and Drug Administration, a...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
- The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
- The Department of Health and Human Services Food and Drug Administration awarded a $354,235 purchase order to Emulate Inc., doing business as Emulate, located in Boston, Massachusetts. The firm fixed price contract is for a Liver Human Emulation System to support the FDA's regulatory review processes. Per the original solicitation, the agency sought to procure a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small...
- The Department of Health and Human Services' Food and Drug Administration awarded a $104,500 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the procurement of five liver human emulation system 24 pack quad liver chip kits. The place of performance will be Emulate's facilities in Boston, Massachusetts. The period of performance is one year, from June 27, 2023 through June 26, 2024. This contract has a total small business set aside designation. The liver chip kits...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order contract to Emulate Inc., a for-profit small business, with a potential value of $218,100.00. The contract is for the delivery of two (2) each of the Human Emulation System ZOE Culture Module 2 and two (2) each of the Orb Hub Module. Emulate's organ-on-a-chip technology is designed to model human biology and supports federal initiatives in areas like personalized medicine,...
- The Department of Health and Human Services Food and Drug Administration awarded a $213,100 firm fixed price purchase order to Emulate Inc. of Boston, Massachusetts. The contract will provide a human emulation system including an ORB-HM1 hub module, two used ZOE-CM2 culture modules, and one new ZOE-CM2 culture module with a one year warranty. Additionally, a service agreement will cover maintenance of the three used items for one year. Per the sole source solicitation, Emulate will satisfy the...
- This federal contract award, valued at $73,050.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., a for-profit organization specializing in organ-on-a-chip technology. The award is for a Restricted Lab Service Program to provide four Zoe CM2 Culture Modules for Organ Chips. The contract is a Firm Fixed Price Purchase Order with a completion date of September 16, 2025. This award does not utilize a set-aside designation. Emulate Inc., also known...
- This federal contract award, valued at $75,000.00, was issued by the Uniformed Services University of the Health Sciences, a defense agency, to Emulate Inc. (doing business as Emulate), a biotechnology company specializing in organ-on-chip technology. The contract is for the delivery of 3-dimensional organ-on-chip technology to support the agency's research initiatives. This is a firm fixed-price purchase order contract with an ultimate completion date of August 31, 2020. The contract was not...